Home | Inova Search App - Admin

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT)
Evaluation of a Biomarker Test for the Early Molecular Profiling of Lung Cancer Utilizing Cytological Samples (ATLAS DHF 011-003P)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Evaluation of a Biomarker Test for the Early Molecular Profiling of Lung Cancer Utilizing Cytological Samples (ATLAS DHF 011-003P)
Evaluation of the hemocompataibility of the Direct Oral Anti-Coagulant apixaban in Left Ventricular Assist Devices (DOAC LVAD)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Evaluation of the hemocompataibility of the Direct Oral Anti-Coagulant apixaban in Left Ventricular Assist Devices (DOAC LVAD)
Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy (REG001-09)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Evaluation Tracking Project: A Prospective Chart Review of Patients Treated with Radiation Therapy (REG001-09)
Evaluation of Transcatheter Aortic Valve Replacement Compared to Surveillance for Patients with Asymptomatic Severe Aortic Stenosis: EARLY TAVR trial

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Evaluation of Transcatheter Aortic Valve Replacement Compared to Surveillance for Patients with Asymptomatic Severe Aortic Stenosis: EARLY TAVR trial
Examining the Microbiome Changes with Fecal Microbiota Transplantation (FMT) for Children with Recurrent Clostridium Difficile Infection

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Examining the Microbiome Changes with Fecal Microbiota Transplantation (FMT) for Children with Recurrent Clostridium Difficile Infection

Summary

Clostridium difficile infection is an intestinal infection that can be life threatening. The incidence is increasing in children, and there is resistance to standard treatment with rising rates of recurrence. In resistant and recurrent cases, manipulation of the microbiome by FMT is an effective treatment. We are examining the intestinal microbiome in children before and after FMT to gain and better understanding of why this treatment is effective and also to improve FMT treatment in the future.
The Exercise Therapy for Advanced Lung Disease Trial: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about The Exercise Therapy for Advanced Lung Disease Trial: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease

Summary

The Exercise Therapy for Advanced Lung Disease Trial: Response and Adaptation to Aerobic Exercise in Patients with Interstitial Lung Disease
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Gene Expression Profiling of Lung Explant and Biopsy Tissue in Subjects with Advanced Lung Disease

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Gene Expression Profiling of Lung Explant and Biopsy Tissue in Subjects with Advanced Lung Disease

Summary

Gene Expression Profiling of Lung Explant and Biopsy Tissue in Subjects with Advanced Lung Disease
Genome Research Alliance for Transplantation (GRAfT)

Submitted by centretek on Sat, 10/15/2022 - 10:29
Read more about Genome Research Alliance for Transplantation (GRAfT)

Summary

This study seeks to evaluate the relationship between donor-derived cell-free DNA and transplant rejection in heart and lung transplant patients. (Advanced Heart Failure group offers this study for heart transplant patients only.) This is a mid-Atlantic, multicenter prospective study to assess utility of donor-derived cell-free DNA as a marker of allograft rejection, cardiac allograft vasculopathy, CMV infection and other post-transplant complications.